Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4/3, Open-label, Single-arm, Multicenter Study To Describe The Safety And Immunogenicity Of 13-valent Pneumococcal Conjugate Vaccine In Adults 50 To 65 Years Of Age And In Children 6 To 17 Years Of Age In India

NCT02034877 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02034877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4/3, Open-label, Single-arm, Multicenter Study To Describe The Safety And Immunogenicity Of 13-valent Pneumococcal Conjugate Vaccine In Adults 50 To 65 Years Of Age And In Children 6 To 17 Years Of Age In India
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2014
Completion date
July 31, 2015
Enrollment
1,200 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of pneumonia and invasive disease caused by the serotypes in 13vpnc